Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure

Clinical trial NCT02808208 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02808208
Sponsor: Mayo Clinic
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

End Stage Renal Disease (ESRD)Vascular Access Complication

Start date: 2017-06-07
Primary completion: 2026-12-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.